Comparison of 6- and 12-core prostate biopsy in Taiwanese men: Impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection

Urologia Internationalis

Volumn 82, Issue 3, 2009, Pages 270-275

  Chiang, I Ni ^a   Chang, Shang Jen ^b   Pu, Yeong Shiau ^a   Huang, Kuo How ^a   Yu, Hong Jen ^a   Huang, Chao Yaun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Prostate biopsy; Prostate cancer; Prostate specific antigen density

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; EPIDIDYMITIS; FEVER; HEMATURIA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATITIS; RECTUM HEMORRHAGE; TAIWAN; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME; URINE RETENTION;

AGED; BIOPSY, NEEDLE; DIGITAL RECTAL EXAMINATION; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TAIWAN; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 65949093051     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209356     Document Type: Article

References (23)

1. Hodge KK, McNeal JE, Terris MK: Random systematic versus directed ultrasound guided transrectal core bipopsies. J Urol 1989;142:71-74
2. Ficarra V, Novella G, Novara G: The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy. Eur Urol 2005;48:932-937.
3. Scattoni V: Systematic prostate biopsies are more and more often becoming saturation biopsies. Eur Urol 2006;50:202-204.
4. Guichard G, Larre S, Gallina A: Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1,000 consecutive patients. Eur Urol 2007;52:430-435.
5. Wakai K: Descriptive epidemiology of prostate cancer in Japan and Western countries. Nippon Rinsho 2005;63:207-212.
6. Colli JL, Colli A: Comparisons of prostate cancer mortality rates with dietary practices in the United States. Urol Oncol 2005;23:390-398.
7. Pu YS, Chiang HS, Lin CC: Changing trends of prostate cancer in Asia. Aging Male 2004;7:120-132.
8. Piffath TA, Whiteman MK, Flaws JA: Ethnic differences in cancer mortality trends in the US 1950-1992. Ethn Healt h 2001;6:105-119.
9. Pu YS: Prostate cancer in Taiwan: epidemiology and risk factors. Int J Androl 2000;23:34-36.
10. Yu HJ, Lai MK: The usefulness of PSA density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer. Urolog y 1998;51:125-130.
11. Epstein JI, Walsh PC, Carter HB: Importance of posterolateral needle biopsies in the detection of prostate cancer. Urology 2001;57:1112-1116.
12. Patel A: Finding a balanced strategy in prostate cancer diagnosis for case detection by prostate needle biopsy at first presentation: 'all for more cores and more cores for all' or individualised sampling regimens? Which way forward? Eur Urol 2007;52:313-315.
13. Elabbady AA, Khedr MM: Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score. Eur Urol 2006;49:49-53.
14. Kim JW, Lee HY, Hong SJ: Can a 12-core prostate biopsy increase the detection rate of prostate cancer versus 6-core? A prospective randomized study in Korea. Yonsei Med J 2004;45:671-675.
15. Gupta NP, Ansari MS, Dass SC: Transrectal ultrasound-guided biopsy for detecting early prostate cancer: an Indian experience. Indian J Cancer 2005;42:151-154.
16. Matsumoto K, Satoh T, Egawa S: Efficacy and morbidity of transrectal ultrasound-guided 12-core biopsy for detection of prostate cancer in Japanese men. Int J Urol 2005;12:353- 360.
17. Ishimura T, Sakai I, Hara I, Eto H, Miyake H: Clinical outcome of transrectal ultrasound-guided prostate biopsy, targeting eight cores, for detecting prostate cancer in Japanese men. Int J Clin Oncol 2004;9:47-50.
18. Kakehi Y, Kamoto T, Ogawa O, Kato T, Tobisu K, Akakura K, et al: Clinical significance of nonpalpable prostate cancer with favorable biopsy features in Japanese men. Eur Urol 2000;37:552-558.
19. Carter HB: PSA scores: should we use a lower threshold? Johns Hopkins Med Lett Health After 502004;17:6.
20. Yu HJ, Chie WC, Hsieh CH: Clinical efficacy of prostate-specific antigen testing in patients with prostate disease. J Formos Med Assoc 1996;95:782-788.
21. Benson MC, Whang IS, Pantuck A: Prostate-specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147:815-816.
22. Benson MC, McMahon DJ, Cooner WH: An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density. World J Urol 1993;11:206-213.
23. Djavan B, Waldert M, Zlotta A: Safety and morbidity of first and repeat transrectal ultrasound-guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 2001;166:856- 860.